BSPG Laboratories 2023 – Brains Bioceutical

BSPG Laboratories

BSPG Laboratories manufactures and supports multiple clinical trials globally. It operates a EU-GMP-compliant facility and is registered with the United Kingdom’s Medicine and Healthcare products Regulatory Agency (MHRA) for the manufacturing and distribution of phytochemical API for human and veterinary medicinal products.

video here when i get it

Brains Bio has invested into facility expansion in the UK to ensure BSPG has the infrastructure in place to grow its annual production capacity and produce API and products for emerging phyto-cannabinoids, to support key customers, existing partners and new customers and partners.

Located in Kent, England
Two EU-GMP-Compliant Facilities
Inspected and registered with the UK MHR
Square Footage 25,000 sq. ft.
CBD Production Capacity 12.6 tons per annum

Active Pharmaceutical Ingredient

The product produced at BSPG’s EU-GMP facility follows ICH Q7 regulations and is entitled to use as an active pharmaceutical ingredient (API) in clinical research and therapeutic drug and product development.

Brains Bio DOES NOT engage in the recreational cannabis market.

Brains Bio is compliant with UK laws and laws of all countries within which Brains Bio is operating and shipping Brains’ CBD API.

Jas Kalsi

An experienced Chartered Professional Accountant with over 30 years of experience in providing personal and corporate taxation, corporate restructuring, financing, public offering and human resources management services. Kalsi is the Chief Financial Officer for Brains Bioceutical Corp., a global manufacturer of naturally-sourced active pharmaceutical ingredients (APIs). In this role, Kalsi is responsible for overseeing and managing the fiscal health of the group, implementing best practices with respect to finance, accounting and internal controls, obtaining funding, providing recommendations on mergers and acquisitions and working collaboratively with the CEO and Board of Directors on strategy. In addition, Kalsi will be responsible to regulatory entities and authorities, including any security exchange commissions.

Kalsi was an audit partner at KPMG focusing on small, medium and large private, government sector and public audit clients. He was the Human Resource Manager in charge of recruiting, staff development and training, and a member of KPMG’s Professional Practice Group. Subsequent to KPMG, Kalsi was the Chief Financial Officer / Chief Executive Officer of a variety of private companies including 6.5 years with a pharmaceutical fulfillment provider and API developer.

Kalsi has a proven track record in hiring top-level senior executives, restructuring companies to minimize tax and maximize cash flows, raising financing and creating a cohesive culture.

Kalsi has a passion for wellness and has created several initiatives and partnered with several leading-edge individuals to help people create and enjoy the best versions of themselves. He sees the use cannabinoids as a major tool to facilitate one’s optimum lifestyle.

With the team and infrastructure in place, Brains Bioceutical has quickly become an industry leader in both the nutraceutical and pharmaceutical cannabinoid industries, with several clinical trials and academic studies underway evaluating the efficacy of cannabinoids to treat major diseases. Under Kalsi’s leadership, Brains Bioceutical has already established market dominance, as it is the only company in the world to sell bulk API commercially around the world, supporting both the pharmaceutical and wellness sectors. With ambitious plans to expand Brains Bioceutical into a global biotech company specializing in cannabinoid health and wellness solutions, Kalsi is pioneering a new frontier in medicinal and wellness solutions across the world.